Characterization of nicotine transport across the tissue plasma membrane by 手賀 悠真
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Nicotine ࡣࠊࢼࢫ⛉ࡢ᳜≀ Nicotiana tabacum ࡟ྵࡲࢀࡿኳ↛ࡢ࢔ࣝ࢝ࣟ࢖ࢻ࡛࠶ࡾࠊ
nicotinic acetylcholine receptor (nAChR) ࡢᙉຊ࡞࢔ࢦࢽࢫࢺ࡛࠶ࡿࠋ㠀ᖖ࡟㧗࠸ẘᛶࢆ᭷













࡛࠶ࡿ⫢⮚࡬ࡢ⛣⾜㐣⛬࡟╔┠ࡋࠊin vivo ࠾ࡼࡧ in vitro ᡭἲࢆ⏝࠸࡚ࡑࡢ㍺㏦ᶵᵓゎ᫂
ࢆ⾜ࡗࡓࠋ




ࡿࡇ࡜ࢆ┠ⓗ࡜ࡋࠊࣛࢵࢺࢆ⏝࠸ࡓ in vivo ゎᯒࢆᐇ᪋ࡋࡓࠋ[3H]Nicotine ࢆࣛࢵࢺ㟼⬦ෆ
࠶ࡿ࠸ࡣ⬻ෆ࡟ᢞ୚ࡋࠊblood-brain barrier (BBB) ࢆ௓ࡋࡓᚠ⎔⾑ᾮ࠿ࡽ⬻࠶ࡿ࠸ࡣ⬻࠿ࡽ
ᚠ⎔⾑ᾮ࡬ࡢ⛣⾜ࢡࣜ࢔ࣛࣥࢫࢆホ౯ࡋࡓ⤖ᯝࠊࣛࢵࢺ BBB ࢆ௓ࡋࡓ⬻࡬ࡢྲྀࡾ㎸ࡳࢡࣜ
࢔ࣛࣥࢫ (CLinf, brain) ࠾ࡼࡧ᤼ฟࢡࣜ࢔ࣛࣥࢫ (CLeff, brain) ࡣࡑࢀࡒࢀ 272 μL/(min࣭ g
brain) ࠊ137 μL/(min࣭g brain) ࡜⟬ฟࡉࢀࠊCLinf, brainࡀ CLeff, brainࡼࡾࡶ 2.0 ಸ㧗࠸ࡇ࡜ࡀ
♧ࡉࢀࡓࠋ௨ୖ࠿ࡽࠊBBB ࡟࠾ࡅࡿ nicotine ⛣⾜ࡣ᤼ฟഃࡼࡾࡶྲྀࡾ㎸ࡳഃࡀඃ఩࡛࠶ࡾࠊ
BBB ࡟࠾࠸࡚ࡇࡢࢡࣜ࢔ࣛࣥࢫࡢᕪࢆ⏕ࡳฟࡍఱࡽ࠿ࡢ nicotine ㍺㏦ᶵᵓࡢᏑᅾࡀ♧၀ࡉ
ࢀࡓࠋࡲࡓࠊblood-retinal barrier (BRB) ࢆ௓ࡋࡓ⥙⭷࡬ࡢྲྀࡾ㎸ࡳࢡࣜ࢔ࣛࣥࢫ (CLinf, retina)
ࡣ 131 μL/(min࣭g retina) ࡜⟬ฟࡉࢀࠊ⣽⬊㛫㝽㏱㐣࣐࣮࣮࡛࢝࠶ࡿ D-mannitol ࠾ࡼࡧ
sucroseࡢ CLinf, retina [D-mannitol, 0.750  μL/(min࣭ g retina); sucrose, 0.264  μL/(min࣭ g retina)] ࡼ
ࡾࡶ 496 ಸ௨ୖ㧗ࡃࠊnicotine ࡣᚠ⎔⾑ᾮ୰࠿ࡽ⥙⭷࡬⤒⣽⬊ⓗ࡟㍺㏦ࡉࢀࡿࡇ࡜ࡀ♧၀ࡉ
ࢀࡓࠋࣛࢵࢺ brain uptake index (BUI) ࠾ࡼࡧ retinal uptake index (RUI) ἲࢆ⏝࠸࡚ nicotine
ࡢ⤌⧊㍺㏦≉ᛶࢆホ౯ࡋࡓ⤖ᯝࠊࡑࡢ BUI ࠾ࡼࡧ RUI್ࡣ⬡⁐ᛶ࠿ࡽண ࡉࢀࡿ್ࡼࡾࡶ
3.5 ಸ௨ୖ㧗࠿ࡗࡓࠋࡲࡓࠊᚠ⎔⾑ᾮ࠿ࡽ⫢⮚࡬ࡢ nicotine ྲྀࡾ㎸ࡳ࡟ࡘ࠸࡚ࡣࠊཷືᣑᩓ
࣐࣮࣮࡛࢝࠶ࡿ[14C]n-butanol ࡼࡾࡶ 1.5 ಸ㧗࠸㏱㐣ᛶࢆ♧ࡋࡓࠋ௨ୖࡢ⤖ᯝ࠿ࡽࠊ⬻ࠊ⥙
⭷࠾ࡼࡧ⫢⮚࡟ࡣ nicotine ࢆಁ㐍ⓗ࡟ྲྀࡾ㎸ࡴᶵᵓࡀᏑᅾࡍࡿࡇ࡜ࡀ♧၀ࡉࢀࡓࠋྛ⤌⧊
࡬ࡢ nicotine ྲྀࡾ㎸ࡳ࡟ᑐࡋ࡚㜼ᐖゎᯒࢆᐇ᪋ࡋࡓ࡜ࡇࢁࠊᚠ⎔⾑ᾮ୰࠿ࡽ⬻࠾ࡼࡧ⥙⭷
࡬ࡢ[3H]nicotine ྲྀࡾ㎸ࡳࡣ㠀ᶆ㆑ nicotine ࡢ࡯࠿ࠊ࢝ࢳ࢜ࣥᛶ໬ྜ≀࡛࠶ࡿ pyrilamine ࠾
ࡼࡧ verapamil (Ca2+ࢳࣕࢿࣝࣈࣟࢵ࣮࢝) ࡟ࡼࡗ࡚᭷ព࡟㜼ᐖࡉࢀࡓࠋࡲࡓࠊᚠ⎔⾑ᾮ୰࠿
ࡽ⫢⮚࡬ࡢ[3H]nicotine ྲྀࡾ㎸ࡳࡣࠊOCTs ࠾ࡼࡧ OCTNs ࡢᇶ㉁࡛࠶ࡿ tetraethylammonium 
(TEA) ࠾ࡼࡧ L-carnitine ྠ᫬ᢞ୚࡟ࡼࡗ࡚ኚ໬ࢆ♧ࡉ࡞࠿ࡗࡓ୍᪉ࠊ㠀ᶆ㆑  nicotine ࠾ࡼ




2. ࣔࢹࣝ⣽⬊࡟࠾ࡅࡿ in vitro nicotine ㍺㏦≉ᛶ  





ࡢ㍺㏦≉ᛶࢆ᫂ࡽ࠿࡟ࡍࡿࡇ࡜࡜ࡋࡓࠋ㍺㏦ゎᯒ࡟࠶ࡓࡾࠊBBB ࠾ࡼࡧ inner BRB ࡟ࡘ
࠸࡚ࡣ᮲௳ⓗ୙Ṛ໬ẟ⣽⾑⟶ෆ⓶⣽⬊ᰴ࡛࠶ࡿ TR-BBB13⣽⬊࠾ࡼࡧ TR-iBRB2⣽⬊ࢆࠊ
⫢⮚࠾ࡼࡧ⫵࡟ࡘ࠸࡚ࡣࢥࣛࢤࢼ࣮ࢮ℺ὶἲ࡟ࡼࡗ࡚༢㞳ࡋࡓ㐟㞳⫢⣽⬊࠾ࡼࡧࣄࢺ⫵
ᡥᖹୖ⓶⒴⏤᮶⣽⬊ᰴ࡛࠶ࡿ A549 ⣽⬊ࢆࡑࢀࡒࢀ⏝࠸ࡓࠋ  




ࡉࢀࡓࠋTR-BBB13 ⣽⬊ࠊTR-iBRB2 ⣽⬊ࠊ㐟㞳⫢⣽⬊࠾ࡼࡧ A549 ⣽⬊࡬ࡢ[3H]nicotine
ྲྀࡾ㎸ࡳ࡟ᑐࡋྛ✀໬ྜ≀ࢆ⏝࠸࡚㜼ᐖゎᯒࢆ⾜ࡗࡓ⤖ᯝࠊ࠸ࡎࢀࡶ᪤▱㍺㏦య  (OCTsࠊ
PMATࠊMATE1ࠊ OCTNsࠊ࠾ࡼࡧ OATs) ࡢ඾ᆺⓗᇶ㉁࡛࠶ࡿ TEAࠊ 1-methyl-4- 
phenylpyridiniumࠊL-carnitineࠊcholine ࠾ࡼࡧ p-aminohippurate ࡛㜼ᐖࡉࢀ࡞࠿ࡗࡓࠋࡇࢀ
ࡽࡢ⤖ᯝࡣࠊnicotine ྲྀࡾ㎸ࡳ࡟࠾ࡅࡿ᪤▱㍺㏦యࡢᐤ୚ࡀᑠࡉ࠸ࡇ࡜ࢆ♧၀ࡋ࡚࠸ࡿࠋ





࡟࠾ࡅࡿ[3H]nicotine ྲྀࡾ㎸ࡳ࡟ྲྀࠊ ࡾ㎸ࡳ᪉ྥ࡜ࡣ㏫ྥࡁࡢ H+໙㓄ࢆ㥑ືຊ࡜ࡍࡿ㍺㏦
యࡀ㛵୚ࡍࡿࡇ࡜ࢆ♧၀ࡋ࡚࠸ࡿࠋA549 ⣽⬊࡬ࡢ nicotine ྲྀࡾ㎸ࡳ࡟㛵ࡋ࡚ࡣࠊ⣽⬊እ
pH పୗ࡟క࠸ࢃࡎ࠿࡞ῶᑡࡀࡳࡽࢀࡓࡶࡢࡢࠊ௚ࡢ⣽⬊࡜ẚ㍑ࡋ኱ࡁ࡞ኚ໬ࡣ♧ࡉࢀ࡞
࠿ࡗࡓࠋ᭱㏆ࡢ◊✲࡛ࣛࢵࢺึ௦ᇵ㣴⫵⬊ୖ⓶⣽⬊࡟࠾ࡅࡿ nicotine ྲྀࡾ㎸ࡳࡣ pH ౫Ꮡ
ᛶࢆ♧ࡍࡇ࡜ࡀሗ࿌ࡉࢀࡓࡇ࡜࠿ࡽࠊA549 ⣽⬊࡜௚⣽⬊㛫࡛ࡢ pH ឤཷᛶࡢᕪ␗࡟ࡣࠊ
✀ᕪࡀ㛵ಀࡍࡿྍ⬟ᛶࡀ⪃࠼ࡽࢀࡿࠋ  
Okura ࡽࡣ TR-BBB13 ⣽⬊ࢆ⏝࠸ࡓゎᯒ࡟࠾࠸࡚ࠊoxycodone ࠾ࡼࡧ pyrilamine ྲྀࡾ㎸
ࡳ࡟᪤▱ࡢ㍺㏦య࡜ࡣ␗࡞ࡿ H+/᭷ᶵ࢝ࢳ࢜ࣥᑐྥ㍺㏦యࡀ㛵୚ࡍࡿࡇ࡜ࢆሗ࿌ࡋ࡚࠸
ࡿ  (Okura et al., Drug Metab Dispos. 36:2005-2013, 2008) ࠋᮏ◊✲࡟࠾࠸࡚ࡶࠊTR-BBB13
⣽⬊࡟࠾ࡅࡿ nicotine ㍺㏦ࡀ pyrilamine ࡟ࡼࡗ࡚ᙉࡃ㜼ᐖࡉࢀ࡚࠸ࡿࡇ࡜ࠊᮏ◊✲࡛᫂ࡽ
࠿࡜࡞ࡗࡓ nicotine ㍺㏦≉ᛶࡀࠊOkura ࡽࡀሗ࿌ࡋࡓ pyrilamine ㍺㏦≉ᛶ࡜ࡼࡃ୍⮴ࡋ࡚
࠸ࡿࡇ࡜࠿ࡽࠊnicotine ࡜ pyrilamine ࡣྠ୍ࡢ᪂つ H+/᭷ᶵ࢝ࢳ࢜ࣥᑐྥ㍺㏦య࡟ࡼࡗ࡚
㍺㏦ࡉࢀࡿྍ⬟ᛶࡀ⪃࠼ࡽࢀࡓࠋࡑࡇ࡛ྛࠊ ⣽⬊࡬ࡢ nicotineྲྀࡾ㎸ࡳ࡟ᑐࡍࡿ pyrilamine
ࡢ㜼ᐖᵝᘧࢆゎᯒࡋࡓ⤖ᯝࠊTR-BBB13 ⣽⬊࠾ࡼࡧ TR-iBRB2 ⣽⬊࡛ࡣࠊpyrilamine ࡟ࡼ
ࡿ nicotine ྲྀࡾ㎸ࡳࡢ➇ྜⓗ࡞㜼ᐖࡀ♧ࡉࢀࠊࡑࡢ㜼ᐖᐃᩘ  (Ki) ࡣࡑࢀࡒࢀ 15.0 μM ࠾
ࡼࡧ 67.7 μM ࡜⟬ฟࡉࢀࡓࠋࡇࢀࡽ Ki್ࡣ TR-BBB13 ⣽⬊࡬ࡢ pyrilamine ྲྀࡾ㎸ࡳ࡟࠾
ࡅࡿ Km್  (28 μM) ࡜㏆ఝࡋࡓࡇ࡜࠿ࡽࠊTR-BBB13 ⣽⬊࠾ࡼࡧ TR-iBRB2 ⣽⬊ࡣඹ㏻ࡢ
᪂つ᭷ᶵ࢝ࢳ࢜ࣥ㍺㏦య࡟ࡼࡗ࡚⣽⬊ෆ࡬㍺㏦ࡉࢀࡿࡇ࡜ࡀ♧၀ࡉࢀࡓࠋ୍᪉࡛⯆࿡῝
࠸ࡇ࡜࡟ࠊ㐟㞳⫢⣽⬊࡛ࡣ pyrilamine ࡟ࡼࡿ nicotine ྲྀࡾ㎸ࡳࡢ㠀➇ྜⓗ࡞㜼ᐖࡀ♧ࡉࢀ
ࡓࠋࡇࢀࡣࠊෆ⓶⣽⬊࡜ୖ⓶⣽⬊࡛ nicotine ㍺㏦యࡀྠ୍࡛࡞࠸ࠊࡶࡋࡃࡣఱࡽ࠿ࡢᶵ⬟
ⓗ㐪࠸ࢆ᭷ࡍࡿྍ⬟ᛶࢆ♧၀ࡋ࡚࠸ࡿࠋNicotine ㍺㏦࡟㛵୚ࡍࡿศᏊᐇయࡢྠᐃࡣࠊࡇࢀ
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